Market Cap | 43.25M | P/E | - | EPS this Y | 68.30% | Ern Qtrly Grth | - |
Income | -20.13M | Forward P/E | -6.86 | EPS next Y | 23.10% | 50D Avg Chg | -18.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -26.00% |
Dividend | N/A | Price/Book | 12.74 | EPS next 5Y | - | 52W High Chg | -78.00% |
Recommedations | 2.50 | Quick Ratio | 1.27 | Shares Outstanding | 82.51M | 52W Low Chg | 12.00% |
Insider Own | 26.43% | ROA | -110.29% | Shares Float | 56.88M | Beta | 1.56 |
Inst Own | 3.63% | ROE | -362.31% | Shares Shorted/Prior | 384.89K/372K | Price | 0.89 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 81,962 | Target Price | 1.00 |
Oper. Margin | - | Earnings Date | May 13 | Volume | 58,060 | Change | 0.00% |
Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was incorporated in 1998 and is based in Seattle, Washington.
Benchmark | Speculative Buy | Apr 8, 24 |